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Abstract
Background: Individuals may develop tolerance to the induction of adverse pulmonary effects
following repeated exposures to inhaled toxicants. Previously, we demonstrated that genetic
background plays an important role in the development of pulmonary tolerance to inhaled zinc
oxide (ZnO) in inbred mouse strains, as assessed by polymorphonuclear leukocytes (PMNs),
macrophages, and total protein in bronchoalveolar lavage (BAL) phenotypes. The BALB/cByJ (CBy)
and DBA/2J (D2) strains were identified as tolerant and non-tolerant, respectively. The present
study was designed to identify candidate genes that control the development of pulmonary
tolerance to inhaled ZnO.
Methods:  Genome-wide linkage analyses were performed on a CByD2F2 mouse cohort
phenotyped for BAL protein, PMNs, and macrophages following 5 consecutive days of exposure to
1.0 mg/m3 inhaled ZnO for 3 hours/day. A haplotype analysis was carried out to determine the
contribution of each quantitative trait locus (QTL) and QTL combination to the overall BAL
protein phenotype. Candidate genes were identified within each QTL interval using the positional
candidate gene approach.
Results: A significant quantitative trait locus (QTL) on chromosome 1, as well as suggestive QTLs
on chromosomes 4 and 5, for the BAL protein phenotype, was established. Suggestive QTLs for
the BAL PMN and macrophage phenotypes were also identified on chromosomes 1 and 5,
respectively. Analysis of specific haplotypes supports the combined effect of three QTLs in the
overall protein phenotype. Toll-like receptor 5 (Tlr5) was identified as an interesting candidate gene
within the significant QTL for BAL protein on chromosome 1. Wild-derived Tlr5-mutant MOLF/Ei
mice were tolerant to BAL protein following repeated ZnO exposure.
Conclusion:  Genetic background is an important influence in the acquisition of pulmonary
tolerance to BAL protein, PMNs, and macrophages following ZnO exposure. Promising candidate
genes exist within the identified QTL intervals that would be good targets for additional studies,
including Tlr5. The implications of tolerance to health risks in humans are numerous, and this study
furthers the understanding of gene-environment interactions that are likely to be important factors
from person-to-person in regulating the development of pulmonary tolerance to inhaled toxicants.
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Introduction
Individuals may develop tolerance to adverse health
effects elicited from repeated exposure to inhaled toxi-
cants in several different occupational and environmental
situations. Pulmonary tolerance can be defined as the
lung's ability to withstand the detrimental effects of a
toxic compound following multiple exposures. There are
several implications of tolerance to human health, having
both advantages and disadvantages with respect to the
development of harmful health effects. Clinical investiga-
tions of zinc oxide (ZnO)- [1], endotoxin- [2], and ozone-
[3-6] induced adverse respiratory effects have demon-
strated inter-individual variability in the capacity to
develop pulmonary tolerance following inhalation expo-
sure. Because these clinical studies are more tightly con-
trolled than epidemiologic studies, they suggest that
genetic background and gene-environment interactions
contribute to the development of pulmonary tolerance in
humans.
We initially characterized the pulmonary tolerance phe-
notype in an outbred mouse model by assessing levels of
BAL protein and polymorphonuclear leukocytes (PMNs)
following single (1X) and 5 daily repeated (5X) exposures
to inhaled ZnO to begin the identification of the genes
regulating the development of pulmonary tolerance to
repeated toxicant exposure [7]. Significant genetic varia-
bility in the development of pulmonary tolerance to ZnO,
endotoxin, and ozone was established in several inbred
strains of mice in a subsequent study [8]. Of the strains
tested, the BALB/cByJ (CBy) strain was tolerant and the
DBA/2J (D2) strain was non-tolerant to BAL protein,
PMNs, and macrophages following repeated ZnO
exposure.
Because inbred mouse strains are virtually identical at all
loci throughout their genome, and also share several chro-
mosomal regions of conserved synteny with humans, they
are an ideal animal model in which to investigate geno-
type-environment interactions and identify genes control-
ling pulmonary responses to inhaled toxicants where no a
priori evidence for their location exists [9]. Inbred strains
of mice have been successfully utilized in quantitative
trait locus (QTL) analyses to identify candidate genes that
control susceptibility to adverse pulmonary responses
induced by a variety of inhaled gases [10-13] and particu-
lates [14,15]. In the present study, a CByD2F2 mouse
cohort was used to determine QTLs linked to the develop-
ment of pulmonary tolerance to BAL protein, PMN, and




Inbred BALB/cByJ (CBy), DBA/2J (D2) and CByD2F1/J
(F1) mice (6–7 weeks of age) were purchased from The
Jackson Laboratory (Bar Harbor, ME). CByD2F1/J mice
were crossed to produce F2 (intercross) offspring in our
laboratory animal facility. All mice were acclimated for at
least 1 week before exposure, housed in a positive pres-
sure environment with a 12-hour light/dark cycle starting
at 6:00 a.m., and provided with water and standard labo-
ratory rodent chow (Purina, Indianapolis, IN) ad libitum
except during exposure. All mice were handled in accord-
ance with the standards established by the U.S. Animal
Welfare Acts set forth in National Institutes of Health
guidelines, and by the New York University School of
Medicine Division of Laboratory Animal Resources.
Zinc oxide generation, characterization, and exposure
Mice were exposed to ZnO (1.0 ± 0.2 mg/m3, mean ± SD)
in stainless steel cages placed inside a 0.07 m3 Plexiglas
chamber. ZnO fumes were generated in a furnace as previ-
ously described [7,16]. The ZnO particles had a mass
median aerodynamic diameter of 0.3 µm and geometric
standard deviation of 1.5. Samples of the chamber atmos-
phere were collected approximately every 40 minutes
from the manifold of the exposure system with poly-
tetrafluoroethylene filters (Type TX40HI20-WW, Pallflex
Products Corp., Putnam, CT), and the ZnO concentration
was determined gravimetrically using a microbalance
(Model C-30, Cahn Instruments, Cerritos, CA).
For linkage analyses, all F2 offspring (n = 299, 138 males
and 161 females) were exposed at 7–12 weeks of age in a
total of seven 5X exposure regimens. Development of pul-
monary tolerance was assessed 24 hours after the fifth
exposure, and exposure group sizes ranged from 36 to 45
animals. All ZnO exposures of F2 mice also contained at
least two CBy, D2, and F1 mice for control purposes.
Bronchoalveolar lavage (BAL)
Mice were euthanized by intraperitoneal injections of ket-
amine HCl (100 mg/kg, Vetalar, Fort Dodge Laboratories,
Inc., Fort Dodge, IA) and sodium pentobarbital (175 mg/
kg, Sleepaway, Fort Dodge Laboratories, Inc.), and the
posterior abdominal aorta was severed. The lungs of each
mouse were lavaged two times with 1.2 ml of Dulbecco's
phosphate buffered saline without Ca2+ or Mg2+ (pH 7.2–
7.4, 37°C, Invitrogen, Carlsbad, CA). The collected BAL
was immediately placed on ice (4°C) following recovery.
Measurement of BAL protein, total cell counts, and differ-
ential cell counts were performed as previously described
[8].Respiratory Research 2005, 6:73 http://respiratory-research.com/content/6/1/73
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DNA isolation and genotyping
Genomic DNA was isolated from kidney tissue of each
phenotyped F2 animal and for CBy, D2, and F1 controls
(Wizard Genomic DNA Purification Kit, Promega, Madi-
son, WI). DNA concentration was determined using a
Beckman DU-650 spectrophotometer, and each sample
was diluted to 10 ng/µl for genotype analysis. PCRs were
performed to genotype F2 offspring for SSLPs located
throughout the mouse genome. Eighty-six unlabeled
primer pairs for SSLPs that differed in length by at least
5% between the CBy and D2 progenitor strains were pur-
chased from Research Genetics (ResGen/Invitrogen). PCR
was performed in 20 µl reaction volumes in 96-well low
profile plates (Fisherbrand, Fisher Scientific, Fairlawn, NJ)
using a PTC-100 thermal cycler (MJ Research, Watertown,
MA). The final concentration for each reaction was: 10
mM Tris-HCl (pH 8.3), 50 mM KCL, 2.5 mM MgCl2, 0.2
mM of each deoxynucleotide triphosphate (Promega),
1.1X Rediload (ResGen/Invitrogen), and 0.132 µM of
each SSLP primer pair. This reaction mixture was added to
100 ng of genomic DNA and 0.45 U of Taq DNA polymer-
ase (Roche Applied Science, Indianapolis, IN). Final reac-
tion mixtures were initially denatured at 94°C for 3 min,
followed by 36 amplification cycles (94°C for 30 seconds,
57°C for 45 seconds, and 72°C for 30 seconds + 1 sec-
ond/cycle). A final extension step at 72°C for 7 min was
followed by refrigeration (4°C). PCR products were differ-
entiated on 3% agarose (Invitrogen) gels and all samples
were visualized by ethidium bromide staining using a
ChemiImager-4400 low light imaging system (Imgen
Technologies, Alexandria, VA) and called by a single
investigator. Any questionable calls in reading the geno-
type from the image were reviewed by a second investiga-
tor and if not resolved, that sample was rerun.
Estimation of loci
The number of independently segregating loci was calcu-
lated using the following formula by Wright [17]: n = (P2
- F1)2/4(|σ 2
F2 -  σ 2
F1|), where n  i s  a n  e s t i m a t e  o f  t h e
number of independent loci; P2 and F1 are the mean BAL
protein responses following 5X ZnO exposure in CBy and
CByD2F1 mice, respectively; σ 2
F2 and σ 2
F1 are the com-
puted variances of the F2 and CByD2F1 mice, respectively.
Linkage analyses
A genome scan was performed to identify associations
between genotypes and the BAL protein phenotype using
a CByD2F2 mouse cohort. All phenotypic data were natu-
ral log normalized to generate a normal distribution to
meet normality assumptions of the Map Manager QT
computer program. Interval analyses were then performed
by fitting a regression equation for the effect of a theoret-
ical QTL at the position of each SSLP and at 1-centimor-
gan (cM) intervals between SSLPs using free, additive,
recessive, and dominant regression models. The regres-
sions and significance of each genotype/phenotype asso-
ciation (or likelihood χ 2 statistic) were calculated by Map
Manager [18]. Permutation tests were performed on the
phenotypic and genotypic data using Map Manager to
generate empirical thresholds for significance following
the methods of Churchill and Doerge [19,20].
For the initial genome scan, the 15 most tolerant and 15
most non-tolerant F2 animals with respect to BAL protein,
PMNs, and macrophages (i.e., the phenotypic extremes)
were used for selective genotyping [9,21]. Interval analy-
ses were done as stated previously, and 10,000 permuta-
tions were performed to generate significant and
suggestive likelihood χ 2 statistic thresholds for the BAL
protein phenotype. Following the identification of a sug-
gestive QTL for BAL protein on chromosome 1, the entire
F2 cohort was examined for additional QTLs. For the BAL
protein phenotype, three additional SSLPs on chromo-
some 1 were analyzed, and a permutation test (10,000
permutations) was performed with only chromosome 1.
This method was similar to that used in previous linkage
studies with inhaled particles and gases that utilized Map
Manager QT [10,14,22]. All likelihood χ 2 statistic thresh-
olds corresponded to those reported in the aforemen-
tioned linkage studies.
Haplotype analysis
A haplotype analysis was carried out similar to that done
previously by Prows and Leikauf to determine the contri-
bution of each QTL and QTL combination to the overall
BAL protein phenotype [15]. This method quantifies any
difference in mean BAL protein levels that are linked with
a particular haplotype. Haplotypes for the following
SSLPs were used for this analysis: D1Mit291 (101.5 cM),
D4Mit254 (82.5 cM), and D5Mit193 (1.0 cM). Mean BAL
protein concentrations for groups of F2 mice with the
same haplotype at each QTL or QTL combinations were
calculated and compared with the mean BAL protein of F2
mice with the other haplotypes to determine the contribu-
tions of these QTLs to the overall BAL protein phenotype.
Results
Phenotypes of the CByD2F2 cohort
To further understand the role of genetic background in
the development of pulmonary tolerance, an F2 (back-
cross) cohort derived from the CBy and D2 progenitors
was phenotyped. The frequency distribution of the BAL
protein, PMN, and macrophage phenotypic responses of
the F2 cohort were within the ranges of similarly exposed
CBy and D2 progenitor mice (Figure 1).
Selective genotyping
A genome-wide scan was performed using the 15 most
tolerant and 15 most non-tolerant mice to initially iden-
tify possible QTLs influencing the development ofRespiratory Research 2005, 6:73 http://respiratory-research.com/content/6/1/73
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Frequency distribution of the number of BAL PMNs (×104), macrophages (×104), and protein (µg/ml) in BALB/cByJ, DBA/2J,  CByD2F1/J, and CByD2F2 mice following 5 consecutive days of exposure to 1.0 mg/m3 ZnO for 3 h/day Figure 1
Frequency distribution of the number of BAL PMNs (×104), macrophages (×104), and protein (µg/ml) in BALB/cByJ, DBA/2J, 
CByD2F1/J, and CByD2F2 mice following 5 consecutive days of exposure to 1.0 mg/m3 ZnO for 3 h/day. Vertical dashed lines 
represent approximate separation points between BALB/cByJ and DBA/2J phenotypes.Respiratory Research 2005, 6:73 http://respiratory-research.com/content/6/1/73
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Genome-wide scan for QTLs associated with the BAL protein phenotype by selective genotyping of the CByD2F2 cohort Figure 2
Genome-wide scan for QTLs associated with the BAL protein phenotype by selective genotyping of the CByD2F2 cohort. For 
each plot, the x-axis is the length of the chromosome in centimorgans (cM), and the y-axis is the likelihood χ 2 statistic value as 
calculated by Map Manager. The upper and lower dashed lines represent significant (LRS = 17.4) and suggestive (LRS = 9.9) 
linkage thresholds, respectively.Respiratory Research 2005, 6:73 http://respiratory-research.com/content/6/1/73
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pulmonary tolerance. Permutation tests on the BAL pro-
tein-extreme data set established a suggestive likelihood
χ 2 statistic threshold of 9.9 and a significant likelihood χ 2
statistic threshold of 17.4. These values were consistent
with the genome-wide probabilities projected by Lander
and Kruglyak [23]. Interval mapping identified a sugges-
tive QTL for the BAL protein phenotype on the distal end
of chromosome 1 (Figure 2). No QTLs were identified for
the PMN and macrophage phenotypes from selective
genotyping.
Genotyping of the entire F2 cohort
The entire F2 cohort was genotyped with three additional
SSLPs on distal chromosome 1 to further analyze the sug-
gestive BAL protein QTL on chromosome 1 identified
from selective genotyping. Interval mapping of the entire
F2 cohort confirmed the QTL on chromosome 1 between
101.0 cM (D1Mit426) and 109.6 cM (D1Mit293) (Figure
3). The peak likelihood χ 2 statistic value for this QTL
exceeded the threshold value of 10.0 for significant link-
age as determined by 10,000 permutations with all loci
from chromosome 1 only.
The entire F2 cohort was further analyzed with the initial
86 SSLPs for the BAL protein, PMN, and macrophage phe-
notypes. Suggestive QTLs for the BAL protein phenotype
that were not previously characterized by selective geno-
typing were identified on chromosome 4 between 53.6
cM (D4Mit146) and 82.5 cM (D4Mit254), and on chro-
mosome 5 between 1.0 cM (D5Mit193) and 18.0 cM
(D5Mit148) (Figure 4). Suggestive QTLs for the BAL PMN
and macrophages were identified on chromosomes 1 and
5, respectively (Figure 5).
Haplotype analysis
Mean BAL protein levels of F2 mice with the same haplo-
type were calculated and compared with the mean BAL
protein levels of F2 mice with the opposite haplotype in
Plot of a significant QTL on chromosome 1 that is associated  with the BAL protein phenotype from analysis of the entire  CByD2F2 cohort Figure 3
Plot of a significant QTL on chromosome 1 that is associated 
with the BAL protein phenotype from analysis of the entire 
CByD2F2 cohort. The x-axis is the length of the chromo-
some in centimorgans (cM), and the y-axis is the likelihood χ 2 
statistic value as calculated by Map Manager. The lower 
dashed line represents the suggestive linkage threshold (LRS 
= 3.8), the middle dashed line represents significant linkage 
threshold (LRS = 10.0), and the upper dashed line represents 
the highly significant linkage threshold (LRS = 18.8).
Plots of suggestive QTLs on chromosomes 4 and 5 associ- ated with the BAL protein phenotype from analysis of the  entire CByD2F2 cohort Figure 4
Plots of suggestive QTLs on chromosomes 4 and 5 associ-
ated with the BAL protein phenotype from analysis of the 
entire CByD2F2 cohort. The x-axis is the length of the chro-
mosome in centimorgans (cM), and the y-axis is the likeli-
hood χ 2 statistic as calculated by Map Manager. The upper 
and lower dashed lines in each plot represent significant (LRS 
= 15.8) and suggestive (LRS = 9.2) linkage thresholds, 
respectively.Respiratory Research 2005, 6:73 http://respiratory-research.com/content/6/1/73
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order to determine the contribution of each QTL and
combinations of QTLs to the overall BAL protein pheno-
type (Figure 6). For each SSLP, F2 animals were genotyped
as a homozygous CBy (CC), a homozygous D2 (DD) or
heterozygous (H). For any individual SSLP, the greatest
difference in mean BAL protein was found for D1Mit291.
F2 mice that were DD at that locus had an average of 156
µg/ml more BAL protein than those mice that had CC or
H haplotypes.
The combinatorial effect of the QTLs on chromosomes 1,
4, and 5 were also examined. For any combination of two
QTLs, F2 mice that had a DD-DD haplotype for markers
on chromosomes 1 and 5 (D1Mit291 and D5Mit193) had
an average of 310 µg/ml more BAL protein than those that
were CC or H (CC/H) for those markers. The greatest dif-
ference in mean BAL protein levels were found in F2 mice
that had a DD-CC/H-DD haplotype for the three QTLs on
chromosomes 1, 4, and 5, (i.e., D1Mit291, D4Mit254, and
D5Mit193), respectively. These mice had an average of
345 µg/ml more BAL protein than those that were CC/H
at the markers across the three chromosomes.
Identification of candidate genes
Within all of the QTLs, candidate genes discovered with
potential roles in controlling the development of toler-
ance to inhaled ZnO are presented in Tables 1 and 2.
These genes were chosen as candidates from a thorough
review of the existing literature and through the positional
candidate gene approach, which combines knowledge of
map position with the mouse transcript map [24].
Plots of suggestive QTLs on chromosomes 1 and 5 associ- ated with the BAL PMN and macrophage phenotypes,  respectively, from analysis of the entire CByD2F2 cohort Figure 5
Plots of suggestive QTLs on chromosomes 1 and 5 associ-
ated with the BAL PMN and macrophage phenotypes, 
respectively, from analysis of the entire CByD2F2 cohort. 
The x-axis is the length of the chromosome in centimorgans 
(cM), and the y-axis is the likelihood χ 2 statistic as calculated 
by Map Manager. The upper and lower dashed lines in each 
plot represent significant (LRS = 15.6) and suggestive (LRS = 
9.2) linkage thresholds, respectively.
Differences in mean BAL protein levels of CByD2F2 mice  with tolerant versus non-tolerant haplotypes at SSLPs repre- senting the identified QTLs Figure 6
Differences in mean BAL protein levels of CByD2F2 mice 
with tolerant versus non-tolerant haplotypes at SSLPs repre-
senting the identified QTLs. Open bars, F2 mice with CC or 
CD genotypes (represented as H). Filled bars, F2 mice with a 
DD genotype (represented as D). Number within each bar is 
the number of F2 mice with the given genotype or haplotype. 
Values are means ± SE. All comparisons of tolerant (open 
bars) haplotypes versus non-tolerant haplotypes (filled bars) 
were significant (P < 0.05, t test).Respiratory Research 2005, 6:73 http://respiratory-research.com/content/6/1/73
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Development of pulmonary tolerance in MOLF/Ei mice
We identified toll-like receptor 5 (Tlr5) as an interesting
candidate gene within the significant QTL for BAL protein
on chromosome 1. A wild-derived inbred mouse strain
called MOLF/Ei (M. m. molossinus) which has non-con-
servative mutations in Tlr5 [25] was phenotyped for BAL
protein following 1X and 5X ZnO exposure to determine
whether Tlr5 may function in the development of pulmo-
nary tolerance (Figure 7). MOLF/Ei BAL protein was sig-
nificantly increased above control values following 1X
ZnO exposure (395 ± 38 µg/ml). However, MOLF/Ei mice
exhibited a tolerant phenotype, as 5X BAL protein values
(215 ± 22 µg/ml) were significantly decreased below that
of the 1X exposure group.
Discussion
Clinical studies on the acquisition of tolerance to inhaled
toxicants suggest that genetic background and gene-envi-
ronment interactions contribute to the development of
pulmonary tolerance in humans. We have previously
determined that a genetic component exists in a mouse
model of pulmonary tolerance to repeated ZnO exposure
[8]. In the present study, we performed linkage analyses
on an F2 mouse population derived from tolerant CBy
and non-tolerant D2 strains to further ascertain the
contribution of genetic background to the development of
pulmonary tolerance, and identify candidate genes that
may be important regulators in the acquisition of
tolerance.
Table 1: Positional candidate genes from linkage analysis of pulmonary tolerance to BAL protein following repeated ZnO exposure.
Chromosome QTL Interval Location Human Orthology Candidate Gene
Chr 1 92–112 cM 94.0 cM 1 (q21-q22) Dfy, Duffy blood group
98.0 cM 1 (q41-q42) Tlr5, toll-like receptor 5
98.6 cM 1 (q41-q42) Adprt1, ADP-ribosyltransferase 1
101.5 cM 1 (q41) Tgfb2, transforming growth factor-β 2
105.0 cM 1 (q32) Traf5, TNF receptor-associated factor 5
106.0 cM 1 (q32-q41) Slc30a1, solute carrier family 30 (zinc transporter), member 1
Chr 4 62–82 cM 62.4 cM 1 (p35-p34.3) Ptafr, platelet-activating factor receptor
65.7 cM 1 (p35.3) Slc30a2, solute carrier family 30, member 2
68.0 cM 1 (p35), 1 (p34-p36) Pla2g2a, 2c, 2d-f, 5, phospholipase A2 groups
75.5 1 (p36.3-p36.2), 1 (p36) Tnfrsf1b, 8, 9, TNF-receptor superfamily members
79.4 cM 1 (p36) Tnfrsf4, TNF-receptor superfamily, member 4
Chr 5 1–20 cM 14.0 cM 7 (q35-q36) Slc4a2, solute carrier family 4, member 2
17.0 cM 7 (p21) Il6, interleukin 6
18.0 cM 7 (pter-qter) Slc30a3, solute carrier family 30 (zinc transporter), member 3
Table 2: Positional candidate genes from linkage analysis of pulmonary tolerance to BAL PMNs and macrophages following repeated 
ZnO exposure.
Chromosome QTL Interval Location Human Orthology Candidate Gene
Chr 1 (PMNs) 51–73 cM 52.0 cM 2 (q33-q37) Ccl20, chemokine (C-C motif) ligand 20
67.4 cM 2 (q21) Cxcr4 chemokine (C-X-C motif) receptor 4
69.9 cM 1 (q31-q32) Il10, interleukin 10
Chr 5 (Macrophages) 43–58 cM 51.0 cM 4 (q13-q21) Areg, amphiregulin
51.0 cM 4 (q13-q21) Btc, betacellulin
51.0 cM 4 (q21) Cxcl1, chemokine (C-X-C motif) ligand 1
51.0 cM 4 (q21) Cxcl2, chemokine (C-X-C motif) ligand 2
53.0 cM 4 (q21) Cxcl5, chemokine (C-X-C motif) ligand 5
53.0 cM 4 (q21) Cxcl9, chemokine (C-X-C motif) ligand 9
53.0 cM 4 (q21) Cxcl10, chemokine (C-X-C motif) ligand 10
56.0 cM 4 (q21-q25) Spp1, secreted phosphoprotein 1Respiratory Research 2005, 6:73 http://respiratory-research.com/content/6/1/73
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Initial analysis using the most tolerant and non-tolerant
F2 mice with respect to BAL protein generated a putative
QTL (designated as the zinc-induced tolerance (ZIT1)
locus) on the distal end of chromosome 1. Further assess-
ment of the entire F2 cohort demonstrated that the QTL
on chromosome 1 attained an LRS value for significant
linkage, and also identified two suggestive QTLs located
on chromosomes 4 and 5. Using a variation of the Wright
equation [17], a minimum of three loci were estimated to
be independently segregating with the BAL protein
phenotype following 5X ZnO exposure, thus in agreement
with the results of the linkage analysis. There are several
approaches that can be pursued to focus in on the QTL
intervals that were identified. For instance, increasing the
number of F2 mice used in the QTL analysis is one alter-
native. The major disadvantage of this, however, is that
segregating QTLs contribute a great deal of phenotypic
"noise," making it problematic when determining
whether or not a given mouse has inherited a particular
QTL [9]. Thus, in order to separate the effects of multiple
loci, congenic mouse strains for each QTL could be gener-
ated, which could then be used to breed multicongenic
lines to examine the existence of any epistatic effects.
Additionally, future studies could employ the use of a
backcross (CByD2F1 × CBy) mouse population to expand
the evaluation of the QTL effects to the overall BAL pro-
tein phenotype.
To measure the contribution of each individual QTL and
each QTL combination to the overall BAL protein pheno-
type, the protein levels for F2 mice with each particular
haplotype were compared. Mice with opposite allelic
combinations for QTLs on chromosomes 1 and 5 had a
difference of 310 µg/ml BAL protein, which accounts for
approximately one-third of the total difference in mean
BAL protein between the parental CBy and D2 strains.
Additionally, the mean BAL protein level of F2 mice with
a DD haplotype for QTLs on chromosomes 1, 4, and 5 was
over half that of the non-tolerant D2 parental strain.
These analyses suggest that although three QTLs were
identified, the development of pulmonary tolerance to
BAL protein is a decidedly complex phenotype that is reg-
ulated by a number of different genes, some of which were
likely not identified by linkage analysis using an F2
cohort.
Candidate genes within the significant QTL on chromo-
some 1 (ZIT1) that could play a role in controlling the
development of tolerance to BAL protein following
repeated ZnO exposure are presented in Table 1. The
Duffy blood group (Dfy) has been shown to modulate the
intensity of inflammation following endotoxin exposure
[26], and has a role in enhancing inflammatory cell
recruitment to sites of inflammation by facilitating move-
ment of chemokines across the endothelium [27]. ADP-
ribosyltransferase 1 (Adprt1) and tumor necrosis factor
(TNF) receptor-associated factor (Traf5) are functionally
associated with nuclear factor (NF)-κ B, a key transcription
factor in the regulation of the inflammatory process
[28,29]. Additionally, activation of ADPRT1 plays a role
in endotoxin-induced BAL protein increases [30,31]. Acti-
vated transforming growth factor-β  has been shown to be
a mediator of bleomycin- and endotoxin-induced lung
permeability (i.e., BAL protein) in mice [32]. Finally,
solute carrier family 30 (zinc transporter), member 1
(Slc30a1) is a metal transporter on the plasma membrane
that confers resistance to zinc and cadmium toxicity in
vitro via an efflux mechanism [33,34].
Candidate genes for BAL protein tolerance identified
within the suggestive QTL intervals on chromosomes 4
and 5 are also presented in Table 1. Notable candidates
include platelet-activating factor receptor (Ptafr) and
phospholipase A2 (Pla2) that have been implicated as
potential mediators of toxicant-induced BAL protein
increases [35-37]. Interleukin (IL)-6 protein was increased
following ZnO exposure in humans [1,38], and was
hypothesized to be an anti-inflammatory suppressor of
ZnO-induced lung injury. Interestingly, increased lung IL-
6 levels have been shown to mediate pulmonary tolerance
BAL protein levels in wild-derived MOLF/Ei mice 24 h after  single (1X) or repeated (5X) exposure to 1.0 mg/m3 ZnO or  air for 3 h Figure 7
BAL protein levels in wild-derived MOLF/Ei mice 24 h after 
single (1X) or repeated (5X) exposure to 1.0 mg/m3 ZnO or 
air for 3 h. Protein levels of BALB/cByJ and DBA/2J mouse 
strains following ZnO exposure are also shown for compari-
son purposes. Values are means ± SE (n = 4–5 MOLF/Ei 
mice/exposure group). * indicates significantly different from 
air-exposed MOLF/Ei controls, P < 0.05 [Student-Newman 
Keuls (SNK) test]. + indicates significantly different from 1X 
MOLF/Ei exposure group, P < 0.05 (SNK test).Respiratory Research 2005, 6:73 http://respiratory-research.com/content/6/1/73
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to ozone in rats [39]. Lastly, solute carrier family 30 (zinc
transporter) members 2 and 3 (Slc30a2 and Slc30a3) have
been identified as zinc transporters that protect against
zinc-induced toxicity in both cell culture and animal
models [40,41]. The development of pulmonary tolerance
to BAL protein in our model could be regulated by any
number of the aforementioned candidate genes. These
candidates will be investigated in future studies of tran-
scriptional and protein regulation to determine their roles
in the development of tolerance.
The suggestive QTLs for tolerance to BAL PMNs and mac-
rophages (on chromosomes 1 and 5, respectively) were
also examined for positional candidate genes (Table 2).
Chemokine (C-C motif) ligand 20 (Ccl20), chemokine
(C-X-C motif) receptor 4 (Cxcr4), and interleukin-10
(Il10) were identified as candidates for BAL PMN toler-
ance. The movement of PMNs into inflammatory tissues
is regulated by chemotactic factors (e.g., chemokines) that
signal through numerous chemokine receptors [42].
PMNs are capable of producing several chemokines and
proinflammatory cytokines, indicating that PMNs may be
important in auto-direction of cell trafficking during
inflammation. CXCR4 expression has been detected on
human PMNs [43], and coordinated chemokine receptor
gene expression may control the tissue-specific migration
and activation status of PMNs into the lung. Human
PMNs are also able to express CCL20 [44], which is able
to recruit immature dendritic cells that play an important
role in the initiation of the immune response as well as
chronic inflammation [45-47]. Finally, IL-10 can be pro-
duced by T cells and is able to diminish PMN influx by
inhibition of expression of proinflammatory chemokines
[48], NF-κ B (via I kappa kinase) [49], and TNF [50], as
well as modulate cells and effector functions associated
with an allergic response. With respect to the BAL macro-
phage phenotype, the epidermal growth factor receptor
(EGFR) ligands amphiregulin (Areg) and betacellulin
(Btc) were identified as candidate genes within the sugges-
tive QTL on chromosome 5. Ligand-dependent activation
of the EGFR by particles rich in metal content lead to acti-
vation of the MAP kinase signaling cascade and cytokine
expression and secretion [51,52]. Secreted phosphopro-
tein 1 (Spp1, also known as osteopontin) was also identi-
fied, and it can act as a chemoattractant for macrophages
[53,54]. Lastly, a host of chemokine (C-X-C motif) ligands
were identified between 51 and 53 cM that could be
involved in macrophage chemotaxis [55]. Again, toler-
ance to BAL PMNs and macrophages may be under the
influence of any number of these candidate genes.
In the present study, we identified toll-like receptor (Tlr5)
as a candidate gene within the significant ZIT1 QTL on
chromosome 1 for tolerance to BAL protein. Toll-like
receptors activate intra-cellular signaling that culminates
in the induction of a multitude of effector genes [56]. Tlr5
has been shown to be an important gene in the immune
response to Gram-positive and Gram-negative bacterial
flagellin [57,58]. We utilized a wild-derived inbred mouse
strain called MOLF/Ei which has non-conservative
mutations in Tlr5 that are associated with a lower level of
expression [25] to determine whether Tlr5 plays a role in
the development of tolerance to BAL protein in our ZnO
model. Because MOLF/Ei mice have a lower level of TLR5
mRNA expression compared to other strains [25], it was
unclear whether we would observe tolerance after a single
exposure to ZnO. Although the MOLF/Ei strain has no
"wild-type" control strain per se, MOLF/Ei mice were tol-
erant to increased BAL protein following repeated ZnO
exposure when compared to the non-tolerant D2 strain.
These data support a role for Tlr5 in the development of
tolerance to BAL protein. Interestingly, Kleeberger and
colleagues identified Tlr4 as a candidate gene in a study of
susceptibility to increased BAL protein in mice following
a single exposure to 0.3 ppm ozone for 72 hours [22],
which also suggests toll-like receptor signaling may be
important in the regulation of inhaled toxicant-induced
changes in BAL protein.
The mechanism through which Tlr5 signaling may regu-
late the development of tolerance to ZnO is unknown.
While endotoxin [59] and bacterial flagellin [60] have
been demonstrated as the primary ligands for Tlr4 and
Tlr5, respectively, the ligand(s) that is responsible for toll-
like receptor signaling following exposure to inhaled
toxicants such as ozone and ZnO is unknown. Although
there have been no studies on endogenous ligands for
Tlr5, several endogenous ligands for Tlr4 have been iden-
tified. For example, fibronectin [61] and hyaluronic acid
[62] are produced by lung cells during lung injury and are
endogenous  Tlr4  ligands. The downstream pathway
through which Tlr5 may regulate the development of tol-
erance to ZnO-induced BAL protein is potentially via NF-
κ B, a transcription factor that is known to induce several
cytokines involved in inhaled ZnO responsiveness such as
IL-8 and IL-6 [1,63]. Furthermore, NF-κ B-dependent gene
expression is decreased in Tlr5-mediated tolerance to flag-
ellin in vitro [64]. Thus, it is plausible that a mutation in
Tlr5, a regulatory element upstream of NF-κ B signaling,
could modulate tolerance to BAL protein from repeated
ZnO exposure. Finally, Tlr5 may function as a danger sig-
nal receptor in the development of ZnO tolerance, con-
sistent with the "danger model" of innate immunity that
explicates activation of the innate immune system by fac-
tors other than foreign antigens [65]. Whatever the case,
much work is needed in understanding how toxicants
function through toll-like receptor signaling mechanisms
in the lung to regulate adverse responses such as BAL
protein.Respiratory Research 2005, 6:73 http://respiratory-research.com/content/6/1/73
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In summary, linkage analysis of a large F2 mouse cohort
identified significant linkage of a QTL (ZIT1) on chromo-
some 1 associated with tolerance to BAL protein following
repeated exposure to inhaled ZnO. Suggestive QTLs were
also identified on chromosomes 4 and 5 for BAL protein,
on chromosome 1 for BAL PMNs, and on chromosome 5
for BAL macrophages. Haplotype analysis suggested that
the combinatorial effects of these three loci contributed to
the overall phenotype, which agrees with the calculated
number of segregating loci. Tlr5 was identified within the
significant QTL for BAL protein on chromosome 1. Wild-
derived Tlr5-mutant MOLF/Ei mice were determined to be
tolerant to BAL protein following repeated ZnO exposure,
suggesting a role for Tlr5 in the development of pulmo-
nary tolerance to inhaled toxicants.
Conclusion
These data substantiate genetic background as an impor-
tant influence in the acquisition of pulmonary tolerance
following exposure to inhaled toxicants such as ZnO, and
promising candidate genes exist within the identified QTL
intervals that would be good targets for additional studies
on the pathogenesis of tolerance.
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